Cargando…

Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes

BACKGROUND: Follicular fluid (FF) is an important micro-environment influencing oocyte growth, its development competence, and embryo viability. The FF content analysis allows to identify new relevant biomarkers, which could be predictive of in vitro fertilization (IVF) outcomes. Inside ovarian foll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scalici, Elodie, Bechoua, Shaliha, Astruc, Karine, Duvillard, Laurence, Gautier, Thomas, Drouineaud, Véronique, Jimenez, Clément, Hamamah, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875704/ https://www.ncbi.nlm.nih.gov/pubmed/27209151 http://dx.doi.org/10.1186/s12958-016-0150-4

Ejemplares similares

Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes
por: Traver, Sabine, et al.
Publicado: (2015)

Outcomes with intracytoplasmic sperm injection of cryopreserved sperm from men with spinal cord injury
por: Bechoua, Shaliha, et al.
Publicado: (2013)

Impact on ICSI outcomes of adding 24 h of in vitro culture before testicular sperm freezing: a retrospective study
por: Desch, Laurent, et al.
Publicado: (2015)

Comparative Gene Expression Profiling in Human Cumulus Cells according to Ovarian Gonadotropin Treatments
por: Assou, Said, et al.
Publicado: (2013)

“Short agonist stop” protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study
por: Mauries, Charlotte, et al.
Publicado: (2022)

Modulation of Gonadotropins Activity by Antibodies
por: Kara, Elodie, et al.
Publicado: (2019)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
por: Inamdar, Dattaprasad B, et al.
Publicado: (2012)

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
por: Haas, Jigal, et al.
Publicado: (2017)

Effects of gonadotropin administration on clinical outcomes in clomiphene citrate‐based minimal stimulation cycle IVF
por: Karakida, Shinya, et al.
Publicado: (2019)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

Serum biomarkers for predicting pregnancy outcome in women undergoing IVF: human chorionic gonadotropin, progesterone, and inhibin A level at 11 days post-ET
por: Kim, Jee Hyun, et al.
Publicado: (2012)

Anti-Müllerian hormone and progesterone levels produced by granulosa cells are higher when derived from natural cycle IVF than from conventional gonadotropin-stimulated IVF
por: Kollmann, Zahraa, et al.
Publicado: (2015)

Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process
por: Scalici, E., et al.
Publicado: (2016)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
por: Biasoni, Valentina, et al.
Publicado: (2011)

Independent value of serum β-human chorionic gonadotropin in predicting early pregnancy loss risks in IVF/ICSI cycles
por: Wang, Liyan, et al.
Publicado: (2022)

The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles
por: Li, Xiaojia, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial
por: Krishna, Deepika, et al.
Publicado: (2016)

The impact of endocrine disruptor chemicals on oocyte/embryo and clinical outcomes in IVF
por: Cabry, Rosalie, et al.
Publicado: (2020)

A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis
por: Tamura, Hiroshi, et al.
Publicado: (2014)

Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
por: Huang, Yan, et al.
Publicado: (2015)

Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges
por: Ou, Jianping, et al.
Publicado: (2015)

Effect of intrauterine injection of human chorionic gonadotropin before fresh embryo transfer on IVF and ICSI outcomes: a meta-analysis
por: Hou, Wenhui, et al.
Publicado: (2018)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
por: Shapira, Moran, et al.
Publicado: (2020)

Interplay Between mTOR and Hippo Signaling in the Ovary: Clinical Choice Guidance Between Different Gonadotropin Preparations for Better IVF
por: Papageorgiou, Kyriaki, et al.
Publicado: (2021)

Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF
por: Nakao, Kazuki, et al.
Publicado: (2021)

Genetic Variants of Gonadotropins and Their Receptors Could Influence Controlled Ovarian Stimulation: IVF Data from a Prospective Multicenter Study
por: Alviggi, Carlo, et al.
Publicado: (2023)

The Effect of Four Different Gonadotropin Protocols on Oocyte and Embryo Quality and Pregnancy Outcomes in IVF/ICSI Cycles; A Randomized Controlled Trial
por: Parsanezhad, Mohammad Ebrahim, et al.
Publicado: (2017)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias
por: Mshaik, Rony, et al.
Publicado: (2021)

Gonadotropins
por: Kase, Nathan
Publicado: (1964)

Gonadotropins
por: Fong, Hanlon
Publicado: (1975)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

High Dosages of Equine Chorionic Gonadotropin Exert Adverse Effects on the Developmental Competence of IVF-Derived Mouse Embryos and Cause Oxidative Stress-Induced Aneuploidy
por: Lin, En, et al.
Publicado: (2021)

Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012)

Apolipoprotein: prospective biomarkers in digestive tract cancer
por: Zhang, Yibo, et al.
Publicado: (2020)

New discoveries on the biology and detection of human chorionic gonadotropin
por: Cole, Laurence A
Publicado: (2009)

The miracle of IVF
por: Chanda, Anusua
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_on1q3ms4besujh1lakc1286fuu